Nedocromil sodium in the treatment of exercise-induced asthma: A meta- analysis

European Respiratory Journal

Volumn 16, Issue 1, 2000, Pages 30-37

  Spooner, C ^a,b,c   Rowe, B H ^a,b   Saunders, L D ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b INSTITUTE OF HEALTH ECONOMICS   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Asthma; Bronchoconstriction; Exercise induced; Meta analysis; Nedocromil; Therapeutic use

Indexed keywords

NEDOCROMIL SODIUM;

ADOLESCENT; ADULT; ARTICLE; BRONCHOSPASM; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; EXERCISE INDUCED ASTHMA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MALE; META ANALYSIS; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA, EXERCISE-INDUCED; FEMALE; HUMANS; MALE; MIDDLE AGED; NEDOCROMIL;

EID: 0033942373     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.2000.16a06.x     Document Type: Article

References (51)

1. Anderson SD. Issues in exercise-induced asthma. J Allergy Clin Immunol 1985; 76: 763-772.
2. Anderson SD, Silverman M, Konig P, Godfrey S. Exercise-induced asthma. Br J Dis Chest 1975; 69: 1-39.
3. Kattan M, Keens TG, Mellis CM, Levison H. The response to exercise in normal and asthmatic children. J Pediatr 1978; 92: 718-721.
4. Virant FS. Exercise-induced bronchospasm: epidemiology, pathophysiology, and therapy. Med Sci Sports Exerc 1992; 24: 851-855.
5. Rupp NT. Diagnosis and management of exercise-induced asthma. Phys Sportsmed 1996; 24: 77-87.
6. Anderson SD. Specific problems: exercise-induced asthma. In: O'Byrne P, Thomson NC, eds. Manual of Asthma Management. London, UK, WB Saunders Co. Ltd, 1995; pp. 621-643.
7. Nastasi KJ, Heinly TL, Blaiss MS. Exercise-induced asthma and the athlete. J Asthma 1995; 32: 249-257.
8. Spector SL. Update on exercise-induced asthma. Ann Allergy 1993; 71: 571-577.
9. Hogshead N, Couzens GS. Asthma and Exercise. New York, NY, USA, Henry Holt and Company, 1989; pp. 1-114.
10. Pierson WE, Voy RO. Exercise-induced bronchospasm in the XXIII summer Olympic Games. N Engl Reg Allergy Proc 1988; 9: 209-213.
11. McFadden ER, Gilbert IA. Exercise-induced asthma. N Engl J Med 1994; 330: 1362-1367.
12. Hendrickson CD, Lynch JM, Gleeson K. Exercise induced asthma: a clinical perspective. Lung 1993; 172: 1-14.
13. Du Buske LM, Horan RF, Sheffer AL. Exercise-induced allergy syndromes. In: Weiler JM, ed. Allergic and Respiratory Disease in Sports Medicine. New York, NY, USA, Marcel Dekker, Inc., 1997; pp. 253-278.
14. Anderson SD, Daviskas E. Pathophysiology of exercise-induced asthma: the role of respiratory water loss in allergic and respiratory disease. In: Weiler JM, ed. Allergic and Respiratory Disease in sports Medicine. New York, NY, USA, Marcel Dekker, Inc., 1997; pp. 87-114.
15. Holgate ST. Clinical evaluation of nedocromil sodium in asthma. Eur J Respir Dis 1986; 69: Suppl. 147, 149-159.
16. R). Eur J Respir Dis 1986; 69: Suppl. 147, 120-131.
17. Canadian Thoracic Society. Canadian Asthma Consensus Conference: Summary of recommendations. Can Respir J 1996; 3: 89-100.
18. American Thoracic Society. Guidelines for the evaluation of impairment/disability in patients with asthma. Am Rev Respir Dis 1993; 147: 1056-1061.
19. Bara A, Milan S, Jones PW. Identifying asthma RCTs with Medline and Embase. 3rd Annual Cochrane Colloquium. Oslo, Norway, 1995.
20. The Cochrane Collaboration. Cochrane Collaboration Handbook. The Cochrane Library [database on disk and CDROM]. updated Mar 1997. Oxford, UK, Update Software, 1997.
21. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomised clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12.
22. Senn S. The AB/BA crossover: past, present and future? Stat Methods Med Res 1994; 3: 303-324.
23. Kenward MG, Jones B. The analysis of data from 2 × 2 crossover trials with baseline measurements. Stat Med 1987; 6: 911-926.
24. Petitti DB. Meta-analysis, Decision analysis, and cost-effectiveness analysis: methods for quantitative synthesis in medicine. New York, NY, USA, Oxford University Press, 1994; pp. 90-110.
25. Follman D, Elliott P, Suh I, Cuter J. Variance imputation for overviews of clinical trials with continuous response. J Clin Epidemiol 1992; 45: 769-773.
26. Boner AL, Miglioranzi P, Piacentini GL, Peroni DG, Andreoli A. Effects of nedocromil sodium pressurized aerosol on exercise challenge using a spacer device and the normal adapter. Pediatr Asthma Allergy Immunol 1988; 2: 207-213.
27. Boner AL, Vallone G, Bennati D. Nedocromil sodium in exercise-induced bronchoconstriction in children. Ann Allergy 1989; 62: 38-41.
28. Debelic M. Nedocromil sodium and exercise-induced asthma in adolescents. Eur J Respir Dis 1986; 69 (Suppl 147): 266-267.
29. DeBenedictis FM, Tuteri G, Bertotto A, Bruni L, Vaccaro R. Comparison of the protective effects of cromolyn sodium and nedocromil sodium in the treatment of exercise-induced asthma in children. J Allergy Clin Immunol 1994; 94: 684-688.
30. Henriksen JM. Effect of nedocromil sodium on exercise-induced bronchoconstriction in children. Allergy 1988; 43: 449-453.
31. Morton AR, Ogle SL, Fitch KD. Effects of nedocromil sodium, cromolyn sodium, and a placebo in exercise-induced asthma. Ann Allergy 1992; 68: 143-148.
32. Novembre E, Frongia GF, Veneruso G, Vierucci A. Inhibition of exercise-induced-asthma (EIA) by nedocromil sodium and sodium cromoglycate in children. Pediatr Allergy Immunol 1994; 5: 107-110.
33. Novembre E, Frongia GF, Lombardi E, Veneruso G, Vierucci A. The preventive effect of nedocromil or furosemide alone or in combination on exercise-induced asthma in children. J Allergy Clin Immunol 1994; 94: 201-206.
34. Oseid S, Mellbye E, Hem E. Effect of nedocromil sodium on exercise-induced bronchoconstriction exacerbated by inhalation of cold air. Scan J Med Sci Sports 1995; 5: 88-93.
35. Roberts JA, Thomson NC. Attenuation of exercise-in-duced asthma by pretreatment with nedocromil sodium and minocromil. Clin Allergy 1985; 15: 377-381.
36. Shaw RJ, Kay AB. Nedocromil, a mucosal and connective tissue mast cell stabilizer, inhibits exercise-induced asthma. Br J Dis Chest 1985; 79: 385-389.
37. Sinclair DG, Winfield CR. Attenuation of exercise-induced asthma by nedocromil sodium and sodium cromoglycate. J Royal Army Med Corps 1990; 136: 105-106.
38. Todaro A, Faina M, Alippi B, Dal Monte A, Ruggieri F. Nedocromil sodium in the prevention of exercise-induced bronchospasm in athletes with asthma. J Sports Med Physl Fitness 1993; 33: 137-145.
39. Bundgaard A, Enehjelm SD, Schmidt A. A comparative study of the effects of two different doses of nedocromil sodium and placebo given by pressurised aerosol in exercise-induced bronchoconstriction. Eur J Allergy Clin Immunol 1988; 43: 493-496.
40. Chudry N, Correa F, Silverman M. Nedocromil sodium and exercise induced asthma. Arch Dis Child 1987; 62: 412-414.
41. Comis A, Valletta EA, Sette L, Andreoli A, Boner AL. Comparison of nedocromil sodium and sodium cromoglycate administered by pressurised aerosol, with and without a spacer device in exercise- induced asthma in children. Eur Respir J 1993; 6: 523-526.
42. DeBenedictis FM, Tuteri G, Niccoli A, Mezzetti D, Rossi L, Bruni L. The effect of cromolyn sodium and nedocromil sodium administered by a pressurized aerosol with a spacer device on exercise-induced asthma in children. Mediators Inflamm 1994; 3 Suppl. 1, S35-S37.
43. DeBenedictis FM, Tuteri G, Pazzelli P, Bertotto A, Bruni L, Vaccaro R. Cromolyn versus nedocromil: duration of action in exercise-induced asthma in children. J Allergy Clin Immunol 1995; 96: 510-514.
44. Konig P, Hordvik NL, Kreutz C. The preventive effect and duration of action of nedocromil sodium and cromolyn sodium on exercise-induced asthma (EIA) in adults. J Allergy Clin Immunol 1987; 79: 64-68.
45. Vilsvik J, Schaanning J. A comparative study of the effect of three doses of nedocromil sodium and placebo given by pressurised aerosol to asthmatics with exercise-induced bronchoconstriction. Ann Allergy 1988; 61: 67-70.
46. Mihalyka MS, Anderson SD, Corte P. Nedocromil sodium in exercise induced asthma. Aust NZ Med 1987; 17: Suppl. 2, 524.
47. DeBenedictis FM, Tuteri G, Pazzelli P, Solinas LF, Niccoli A, Parente C. Combination drug therapy for the prevention of exercise-induced bronchoconstriction in children. Ann Allergy Asthma Immunol 1998; 80: 352-356.
48. Canadian Pharmaceutical Association. Compendium of Pharmaceuticals and Specialties. 32 ed. Ottawa, Canada, Canadian Pharmaceutical Association, 1997.
49. Lloyd J. Clinical trial design. In: Lloyd J, Raven A, eds. Handbook of Clinical Research 2 ed. Edinburgh, UK, Churchill Livingstone, 1994; pp. 92-113.
50. Shapiro SH, Louis TA. Clinical Trials: Issues and Approaches. New York, NY, USA, Marcel Dekker Inc., 1983.
51. Senn S, Hildebrand H. Crossover trials, degrees of freedom, the carryover problem and its dual. Stat Med 1991; 10: 1361-1374.